18-31593832-A-G

Variant names:

• chr18-31593832-A-G
• rs1080094
• NM_000371.4:c.200+806A>G

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_Strong BP6 BA1

The NM_000371.4(TTR):​c.200+806A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.513 in 152,054 control chromosomes in the GnomAD database, including 22,973 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in Lovd as Benign (no stars).

• Frequency: Genomes: 𝑓 0.51 (22973 hom., cov: 32)
• Consequence: TTR NM_000371.4 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.377

Genes affected

TTR (HGNC:12405): (transthyretin) This gene encodes one of the three prealbumins, which include alpha-1-antitrypsin, transthyretin and orosomucoid. The encoded protein, transthyretin, is a homo-tetrameric carrier protein, which transports thyroid hormones in the plasma and cerebrospinal fluid. It is also involved in the transport of retinol (vitamin A) in the plasma by associating with retinol-binding protein. The protein may also be involved in other intracellular processes including proteolysis, nerve regeneration, autophagy and glucose homeostasis. Mutations in this gene are associated with amyloid deposition, predominantly affecting peripheral nerves or the heart, while a small percentage of the gene mutations are non-amyloidogenic. The mutations are implicated in the etiology of several diseases, including amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis and carpal tunnel syndrome. [provided by RefSeq, Aug 2017]

ACMG classification

Verdict is Benign. Variant got -13 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.9).
• BP6: Variant 18-31593832-A-G is Benign according to our data. Variant chr18-31593832-A-G is described in Lovd as [Benign].
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.814 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
TTR	NM_000371.4	c.200+806A>G		intron_variant	Intron 2 of 3	ENST00000237014.8	NP_000362.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
TTR	ENST00000237014.8	c.200+806A>G		intron_variant	Intron 2 of 3	1	NM_000371.4	ENSP00000237014.4
TTR	ENST00000649620.1	c.200+806A>G		intron_variant	Intron 4 of 5			ENSP00000497927.1
TTR	ENST00000610404.5	c.104+806A>G		intron_variant	Intron 2 of 3	5		ENSP00000477599.2
TTR	ENST00000541025.2	n.226+806A>G		intron_variant	Intron 2 of 2	2

Frequencies

GnomAD3 genomes AF: 0.513 AC: 77933 AN: 151936 Hom.: 22905 Cov.: 32

Gnomad AFR AF: 0.821

Gnomad AMI AF: 0.391

Gnomad AMR AF: 0.493

Gnomad ASJ AF: 0.444

Gnomad EAS AF: 0.441

Gnomad SAS AF: 0.413

Gnomad FIN AF: 0.281

Gnomad MID AF: 0.585

Gnomad NFE AF: 0.384

Gnomad OTH AF: 0.507

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.513 AC: 78066 AN: 152054 Hom.: 22973 Cov.: 32 AF XY: 0.507 AC XY: 37682 AN XY: 74320

Gnomad4 AFR AF: 0.821

Gnomad4 AMR AF: 0.493

Gnomad4 ASJ AF: 0.444

Gnomad4 EAS AF: 0.441

Gnomad4 SAS AF: 0.415

Gnomad4 FIN AF: 0.281

Gnomad4 NFE AF: 0.384

Gnomad4 OTH AF: 0.510

Alfa AF: 0.458 Hom.: 2256

Bravo AF: 0.544

Asia WGS AF: 0.470 AC: 1640 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.90
CADD	Benign	0.63
DANN	Benign	0.36

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.010		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs1080094; hg19: chr18-29173795;